CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IV, Randomised, Single Masked Study Investigating the Efficacy and Safety of Ranibizumab "Inject and Extend" Using an Intensive Retinal Fluid Retreatment Regimen Compared to a Relaxed Retinal Fluid Retreatment Regimen in Patients With Wet Age-related Macular Degeneration (AMD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01972789
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:32.076024+00:00
Published At: 2019-10-23T00:00:00+00:00
Record Updated At: 2019-10-23
Results Posted At: 2019-10-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-10-23"
protocolSection.identificationModule.nctId: "NCT01972789"
protocolSection.identificationModule.officialTitle: "A Phase IV, Randomised, Single Masked Study Investigating the Efficacy and Safety of Ranibizumab \"Inject and Extend\" Using an Intensive Retinal Fluid Retreatment Regimen Compared to a Relaxed Retinal Fluid Retreatment Regimen in Patients With Wet Age-related Macular Degeneration (AMD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-10-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.